| scholarly article | Q13442814 |
| P50 | author | John Chiang | Q68164337 |
| Feng Li | Q85652273 | ||
| P2093 | author name string | Shannon Boehme | |
| Jessica M Ferrell | |||
| P2860 | cites work | FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade | Q45183082 |
| The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity. | Q50999029 | ||
| Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. | Q51482499 | ||
| Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. | Q52519814 | ||
| Ileal bile acid transport regulates bile acid pool, synthesis, and plasma cholesterol levels differently in cholesterol-fed rats and rabbits | Q73462744 | ||
| 27-hydroxycholesterol: production rates in normal human subjects | Q77959231 | ||
| A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis | Q82824308 | ||
| Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis | Q93919581 | ||
| Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors | Q24290397 | ||
| Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression | Q24336351 | ||
| Integrated physiology and systems biology of PPARα | Q24564130 | ||
| The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control | Q24629879 | ||
| Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation | Q24652848 | ||
| Bile acids: regulation of synthesis | Q24658139 | ||
| Bile acid signaling in metabolic disease and drug therapy | Q28244875 | ||
| Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells | Q28247809 | ||
| Farnesoid X receptor is essential for normal glucose homeostasis | Q28591952 | ||
| Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice | Q34304725 | ||
| Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist | Q34326973 | ||
| Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice. | Q34451281 | ||
| Impact of physiological levels of chenodeoxycholic acid supplementation on intestinal and hepatic bile acid and cholesterol metabolism in Cyp7a1-deficient mice | Q34980363 | ||
| Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis | Q35181443 | ||
| Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity | Q35693984 | ||
| Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. | Q35703158 | ||
| Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids. | Q36060415 | ||
| Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid | Q36114905 | ||
| beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes | Q36977082 | ||
| Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice | Q36979341 | ||
| PCSK9: a convertase that coordinates LDL catabolism | Q37173223 | ||
| Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids | Q37333477 | ||
| A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus | Q37507016 | ||
| Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization | Q38204530 | ||
| SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase | Q39981968 | ||
| Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis | Q42103139 | ||
| Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice | Q42110387 | ||
| Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice | Q44317085 | ||
| Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse | Q44441744 | ||
| Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions | Q45041992 | ||
| Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. | Q45108263 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1144-1154 | |
| P577 | publication date | 2016-05-04 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders | |
| P478 | volume | 57 |
| Q92435693 | Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters |
| Q57119190 | Animal models to study bile acid metabolism |
| Q57128767 | Bile acid metabolism and signaling in liver disease and therapy |
| Q47645986 | Bile acid metabolism in liver pathobiology |
| Q94475532 | Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease |
| Q90731281 | Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs |
| Q41649308 | Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis |
| Q92255685 | Comparative Effects and Mechanisms of Chitosan and Its Derivatives on Hypercholesterolemia in High-Fat Diet-Fed Rats |
| Q92666284 | Correlation between 12α-hydroxylated bile acids and insulin secretion during glucose tolerance tests in rats fed a high-fat and high-sucrose diet |
| Q91143156 | Deficiency of Both Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice |
| Q55080645 | Deficiency of cholesterol 7α-hydroxylase in bile acid synthesis exacerbates alcohol-induced liver injury in mice. |
| Q90310328 | Gut microbiota and cardiovascular disease: opportunities and challenges |
| Q57818789 | Interactions Between Regulatory Variants in CYP7A1 (Cholesterol 7α-Hydroxylase) Promoter and Enhancer Regions Regulate CYP7A1 Expression |
| Q92106425 | Intestinal Absorption of Bile Acids in Health and Disease |
| Q57116884 | Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression |
| Q58602512 | Maternal High-Fat Diet Programs Offspring Liver Steatosis in a Sexually Dimorphic Manner in Association with Changes in Gut Microbial Ecology in Mice |
| Q53705753 | Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease. |
| Q47162245 | Recent advances in understanding bile acid homeostasis. |
| Q89612196 | Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice |
| Q33658912 | SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model |
| Q38740970 | Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes |
| Q89520624 | The acidic pathway of bile acid synthesis: Not just an alternative pathway☆ |
| Q53690107 | Unexplained reciprocal regulation of diabetes and lipoproteins. |
Search more.